HomeDRMAW • NASDAQ
add
Dermata Therapeutics
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.23M | 78.02% |
Net income | -3.17M | -84.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.14M | -7.35% |
Total assets | 6.69M | -8.69% |
Total liabilities | 1.95M | 112.27% |
Total equity | 4.74M | — |
Shares outstanding | 2.04M | — |
Price to book | 0.00 | — |
Return on assets | -135.26% | — |
Return on capital | -200.12% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.17M | -84.57% |
Cash from operations | -3.42M | -92.98% |
Cash from investing | — | — |
Cash from financing | 4.62M | 13,131.36% |
Net change in cash | 1.20M | 166.22% |
Free cash flow | -2.22M | -87.48% |
About
Founded
2014
Website
Employees
8
